fig1
![Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel](https://image.oaes.cc/d8c9d4d7-73b0-49b9-9b58-a134b701fb41/3425.fig.1.jpg)
Figure 1. Workflow of CTC isolation from CRPC patient peripheral blood and multiplex confocal microscopy imaging for drug-target engagement quantification. CTC: circulating tumor cell; mCRPC: metastatic castration-resistant prostate cancer
Figure 1. Workflow of CTC isolation from CRPC patient peripheral blood and multiplex confocal microscopy imaging for drug-target engagement quantification. CTC: circulating tumor cell; mCRPC: metastatic castration-resistant prostate cancer
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/